Xtant Medical Holdings XTNT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Orthobiologics | $15.61M-13.6% | $18.3M0.0% | $17.15M+3.4% | $19.37M+20.1% | $18.07M+17.2% | |
| Spinal Implant | $5.28M-52.9% | $9.41M-19.7% | $10.62M-6.5% | $11.07M-19.9% | $11.21M-10.0% | |
| Percentage Of Net Revenue by Product | ||||||
| Orthobiologics | 75%+20.0pp | —— | 52%-7.0pp | 55%+1.0pp | 55%0.0pp | |
| Spinal Implant | 25%-9.0pp | —— | 32%-9.0pp | 31%-15.0pp | 34%-11.0pp | |
| Revenue by Geography | ||||||
| Non Us | $177K-93.6% | $2.47M-10.1% | $2.94M+13.4% | $3.28M— | $2.79M— | |
| US | $20.71M-31.2% | $29.89M+3.9% | $30.31M+19.6% | $32.13M+22.3% | $30.12M+19.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Xtant Medical Holdings break its business down?
- Xtant Medical Holdings (XTNT) reports revenue by product across 2 parts — Orthobiologics and Spinal Implant. Each is extracted from the segment footnotes and tracked over time.
- Where does Xtant Medical Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Xtant Medical Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
